U.S. Regulators Rejected Elon Musk’s Bid To Test Brain Chips In Humans, Citing Safety Risks
On at least four occasions since 2019, Elon Musk has predicted that his medical device company, Neuralink, would soon start human trials of a revolutionary brain implant to treat intractable conditions such as paralysis and blindness.
Tuesday 07 March 2023 | 16:40
A Synchron animation explaining its brain implant. The company has regulatory approval to test a device in humans that, like Neuralink’s implant, aims to help paralyzed people type with their minds. Photo: Reuters
On at least four occasions since 2019, Elon Musk has predicted that his medical device company, Neuralink, would soon start human trials of a revolutionary brain implant to treat intractable conditions such as paralysis and blindness.
Yet the company, founded in 2016, didn’t seek permission from the U.S. Food and Drug Administration (FDA) until early 2022 – and the agency rejected the application, seven current and former employees told Reuters.
The rejection has not been previously reported.
Related stories
To read more, click on this link to access the full article and details:
https://eedition.fijisun.com.fj/subscriptionplans
Source: Reuters
Feedback: jyotip@fijisun.com.fj
